Nov 13 2026

CBN Seminar: Jacqueline Barker, PhD

Information
Friday, November 13, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs Conference Room D406

Substance use disorder (SUD) frequently co-occurs with comorbid conditions such as chronic pain or infection, however preclinical models typically investigate SUD in isolation. Our lab believes that developing complex models will yield greater insight into underlying mechanisms with implication for therapeutic development. This talk will describe aberrant cocaine-seeking behavior in dual mouse models of co-occurring cocaine use and HIV infection (EcoHIV infection of wild-type mice and HIV-1 infection of humanized mice). In particular, we identify increased resistance to extinction of cocaine seeking and elevated reinstatement. In addition, it will describe nucleus accumbens neuroimmune alterations and characterize astrocyte morphological consequences of infection. Finally, it will include data on the ability of a promising pharmacological target, troriluzole, to suppress reinstatement in control populations, with mitigated efficacy in the context of HIV.

Nov 06 2026

R.A.D.D. Seminar: "NUDT2-Mediated Decapping of m𝟔Am-Capped mRNAs Contributes to Neurogenesis"

Information
Friday, November 6, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs Conference Room D406

Presented by: Anil Kumar Vijjamarri  

Dr. Mike Kiledjian's Lab
Cell Biology and Neuroscience Department

Oct 30 2026

CBN Seminar: Juan Matute, PhD

Information
Friday, October 30, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs Conference Room D406
Oct 16 2026

CBN Seminar: Sameer Bajikar, PhD

Information
Friday, October 16, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs Conference Room D406

"Connecting the dots: tying together rare disease-causing genes"

Abstract: Nearly 1 in 20 children are diagnosed with a neurodevelopmental disorder (NDD). Sequencing efforts have identified hundreds of genes whose loss-of-function will cause a NDD; despite knowing the genetic causes of many NDDs, we will lack targeted treatments for these disorders. The convergence of symptomology across NDDs suggests there may also be underlying molecular convergence across NDDs that drive brain dysfunction. We use the gene methyl-CpG-binding protein 2 (MECP2) as an exemplar gene whose genetic disruption causes two severe NDDs: Rett syndrome and MECP2 duplication syndrome (MDS). Studying the converging and diverging molecular pathways dysregulated in Rett and MDS revealed that MECP2 directly regulates growth-differentiation factor 11 (GDF11) in the brain; however, the role of GDF11, a TGF-beta ligand, in normal or abnormal brain development has not been deeply studied. Understanding how GDF11 functions is critical, as we discovered that mutations in GDF11 drive neurological dysfunction in patients. The Bajikar lab studies the interplay between genes that drive monogenic NDDs, like MECP2 and GDF11, to discover the underlying mechanisms that are broadly important for brain development in function and how these mechanisms go awry in NDDs.

Oct 09 2026

R.A.D.D. Seminar: Maxwell Madden

Information
Friday, October 9, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs Conference Room D406

"Anterior Cingulate Cortex in a Probabilistic Decision-Making Task"

Oct 02 2026

CBN Seminar: Annelise Snyder, PhD

Information
Friday, October 2, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs Conference Room D406

"Defining innate immune mechanisms underlying microglial control of brain metastases in breast cancer"

Abstract: Central nervous system (CNS) metastases in breast cancer patients account for approximately 30% of patient deaths. The curative efficacy of current treatments for brain metastases is almost nonexistent, highlighting a critical need to design novel therapies for metastatic breast cancer patients. One drug development strategy involves activating the immune system to identify and eliminate metastatic tumor cells. Tissue-resident macrophages, including microglia of the CNS, operate as innate immune sentinels that are optimally positioned to interact with insults such as transformed cells. The goal of our lab’s research program is to establish a better understanding of the specific signaling mechanisms that promote protective microglial immunosurveillance of brain metastases. Our current work has identified a beneficial role for the inflammatory kinase RIPK3 and type I interferon (IFN) in promoting tumor immunosurveillance by microglia. Ongoing work in our lab is centered on defining the molecular mechanisms underlying how type I IFN and RIPK3 coordinate microglial activation and function in the context of CNS metastasis. By exploring the pre-clinical efficacy of manipulating these pathways, we aim to identify novel immunotherapy targets in tissue-resident macrophages that could be leveraged in future translational studies aimed at restoring functional tumor immunosurveillance within the CNS.

Sep 25 2026

R.A.D.D. Seminar: Vishal Karuppusammy

Information
Friday, September 25, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs Conference Room D406

"CNS-derived SerpinA3n exerts a protective function during WNV orthoflavivirus encephalitis."

Sep 18 2026

Promotion Seminar: Max Tischfield

Information
Friday, September 18, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs Conference Room D406

“Traversing The Brain: Uncovering mechanisms Of Human Disease Across genes, Circuits, And Systems”

Sep 11 2026

Promotion Seminar: David Margolis, PhD

Information
Friday, September 11, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs Conference Room D406

"Neural Circuits For Sensorimotor Integration: Plasticity To Pain"

Sep 04 2026

Promotion Seminar: Ping Xie

Information
Friday, September 4, 2026 12:00 PM - 1:00 PM
Event Type: Seminars
Nelson Labs - Conference Room D406

“COMPLEX MECHANISMS OF IMMUNE REGULATION AND CANCER PATHOGENESIS”